FOLD vs JD · rev $528.3M vs P/E 7.6, rev $187.20B
Amicus Therapeutics Inc (FOLD) versus JD.com Inc Adr (JD) — a side-by-side from cached financials, not a winner call.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
JD.com Inc Adr (JD) is a internet retail company listed on US.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
Latest reported JD revenue for 2025-12-31 was $187.20B. Net income was $3.31B. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. JD currently screens at market cap $45.56B and trailing P/E 7.6.
FOLD currently screens at market cap $1.80B. JD currently screens at market cap $45.56B and trailing P/E 7.6.
Not investment advice. Open the FOLD and JD stock pages for the full models.
Not investment advice.